TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: User satisfaction with mHealth platform
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PPT (pressure pain threshold)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak pain intensity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Æsthetic evaluation after treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Working time for the clinician
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incidence of phrenic nerve palsy
Endpoint domain: Adverse events/effects
Primary endpoint: Chance of being caries free
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative IPSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bladder spasm incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of Alzheimer's disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Complete clearance of nail psoriasis (NAPSI 0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean percent improvement rates from baseline NAPSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean PSSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Core volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Core-penumbra ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: peak force production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial Grading System (FGS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial Disability Index‐‐Physical (FDIP) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial Disability Index‐‐Social (FDIS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean titers of spike-specific binding antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Impact of youth and family engagement on research and service pathway quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Positive and Negative Syndrome Scale Total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Personal and Social Performance scale score
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: DeltaFEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: high-sensitivity C-reactive protein level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality risk associated with systolic blood pressure
Endpoint domain: Mortality/survival
Primary endpoint: OHIP-14 prevalence scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perceived mental effort
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: UE-FMA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MEP amplitude improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MEP latency decrement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hand dexterity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of cardiovascular death, non-fatal myocardial infarction, non-fatal ischemic stroke, or unstable angina
Endpoint domain: Mortality/survival
Primary endpoint: Scale of mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein‐bound AGE Nε‐(carboxymethyl)lysine (CML)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Family function level
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Skeletal-related events (SSE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPT30
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean CCI at 30-day postoperative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in trial withdrawals between arms
Endpoint domain: Adverse events/effects
Primary endpoint: Bar velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete reperfusion after PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Normal myocardial perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Levels of NT-proBNP at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SRT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the amount of alcohol consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean cost of prescription and injectable drugs per encounter
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Causal association between IBS and migraine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain score levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: opioid medication use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: performance time in GIFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phonemic fluency test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Emotional regulation skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: BMISDS reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of moderate to severe postoperative sore throat
Endpoint domain: Adverse events/effects
Primary endpoint: quantity of rescue fentanyl used in post-anesthesia care unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time required for eye opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive empathy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Affective empathy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean total AOM cost per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Correct depth of catheter insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year rwDFS
Endpoint domain: Mortality/survival
Primary endpoint: change in carotid plaque score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: intention to eat less unhealthy food
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: attention bias to HP food images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in rectal V70 dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in late rectal toxicity severity
Endpoint domain: Adverse events/effects
Primary endpoint: Bowel quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: BOLD response during punishment feedback
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of VTE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Need for infliximab dose escalation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Median calprotectin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total TGMD‐3 percentile improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: locomotor skills percentile improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ball skills percentile improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: convulsive seizure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: symptomatic improvement in stool frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: symptomatic improvement in excessive wind
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Degree of asymmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Adherence to patient-centred TB treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Good provider-patient relationship
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Success rates of AU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clavien-Dindo grade I complications
Endpoint domain: Adverse events/effects
Primary endpoint: Static and dynamic balance (EO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 48 h need for metoclopramide
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Serious adverse events (SAEs) related to NBTXR3
Endpoint domain: Adverse events/effects
Primary endpoint: unplanned HF-related rehospitalizations or all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: pNfL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: KYN pathway activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED revisit rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Lower intentions to vape
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean time-to-completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NTB 5‐item composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Dementia Rating‐Sum of Boxes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of low protein level
Endpoint domain: Adverse events/effects
Primary endpoint: Flexural rigidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sclerozation of the NP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Low back pain
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of healthy live births
Endpoint domain: Mortality/survival
Primary endpoint: Days to goal calorie
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: FI incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Serum levels of barrier function biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: flap survival rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sixth-month NRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: strength/power-related parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving IOP ≤ 21 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in neovascularization grades
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seizure cessation rate within 30 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: endometrial hyperplasia rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of Micra™ implantation in the mid-septum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: X-ray radiation dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EPA plus DHA levels in erythrocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: EPA plus DHA levels in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: EPA plus DHA levels in whole blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Risk of developing late AMD after cataract surgery
Endpoint domain: Mortality/survival
Primary endpoint: Mean number of days alive and out of the hospital
Endpoint domain: Mortality/survival
Primary endpoint: cumulative risk of death during remission
Endpoint domain: Mortality/survival
Primary endpoint: plasma cortisol at 60 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: salivary cortisol or cortisone at 60 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: reduction in limb edema volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in quality of life scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Insulin levels (FINS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Composite of death, myocardial infarction, stroke, systemic embolism, thrombosis, and major bleeding
Endpoint domain: Mortality/survival
Primary endpoint: Major, disabling, or life-threatening bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: angle trunk rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal oxygen uptake changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: >10% weight loss at three months post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 5-year rate of SVD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AF recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: AF burden after ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: somatic pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scale for the Assessment and Rating of Ataxia score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: International Cooperative Ataxia Rating Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Medication Adherence Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental Component of HRQoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Greater resilience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fewer perceived stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ω‐3 index of erythrocyte membranes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arachidonic acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with encounters for guideline recommendations
Endpoint domain: Delivery of care
Primary endpoint: Risk of renal death
Endpoint domain: Mortality/survival
Primary endpoint: Time to fatal/nonfatal cardiovascular events
Endpoint domain: Mortality/survival
Primary endpoint: Lymphoma progression at week 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Differences in nutrient intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: System Usability Scale preference
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall Neuropathy Limitations Scale total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total number of ablations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: mHHS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HOS-ADL score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean TSH levels after follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: percentage of PMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: VSL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Freedom from CD-TLR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rutherford class
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean gingival bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: annualized change in grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: faster gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DPB (Diastolic Blood Pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recidivism rates (rearrests or return to incarceration)
Endpoint domain: Mortality/survival
Primary endpoint: Self-reported MVPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength and flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative serum level of parathyroid hormone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: relative exposure ratio between the operators' exposure and the patient's exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-participation rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean Artery Pressure (MAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: NRS score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: AFP response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dice similarity coefficient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Positive predictive value (PPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensitivity coefficient (SC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of neutrophils at 12 h postoperation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Parental well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maternal parenting behavior (telling a story or singing to the child)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: device-associated mortality risk
Endpoint domain: Mortality/survival
Primary endpoint: improved functioning (New York Heart Association class II)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-efficacy for support provision
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: positive dyadic coping
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: overall relationship adjustment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Infant self-regulation problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infant communication problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSE (Cortical Excitability)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: injury severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vital signs at admission and disposition at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relationship between stress and drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in household female vector abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LED food selection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAS28‐ESR score changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDAI score changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of sitting time during lessons and breaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pregnancy related anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fear of giving birth
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: worries about bearing a handicapped child
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in KI score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing